Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CLINICAL TRIALS LIABILITY INSURANCE COVERAGE The policy provides compensation to clinical trials subjects/participants in the event of these individuals suffering an injury which is directly attributable to their involvement in the trial. Cover is provided on a no-fault basis, which means that the policy will be triggered if causation has been proven. THE NEED: Research and Development (R&D) The pursuit of drug discovery and pharmaceutical development is inherently complex, time consuming, costly, and fraught with risk. Increased governmental regulation, competition and the push for rapid drug development, combined with today’s litigious business environment, is driving increased demand for liability insurance cover. Patient safety is of utmost importance in pharmaceutical development but unavoidable accidents can occur. Strict protocols must be observed before a new medication can be ethically approved and internationally regulators require that the clinical trial sponsors carry clinical trials liability cover in the event of trial-related injuries to participants. South Africa is no different - the National Health Act No. 61 of 2003 and the SA Guidelines provide the principles on which clinical trials are to be conducted. The guidelines are related to the regulatory requirements of the Medicines Control Council. Section 4.11 of “The Guidelines for Good Practice in the conduct of Clinical Trials in Human Participants in South Africa” issued by the Department of Health, requires that all participants in clinical trials are covered by comprehensive insurance (no-fault insurance) for injury and damage; without which clinical trials cannot be conducted. Clearly a high-risk area, clinical trial liability requires unique coverage to provide the maximum insurance protection. Considering that there are literally tens of thousands of trials taking place on a global scale today, and some predictions suggest a 10% growth in this sector through to 2018, liability cover opportunities in this market will expand exponentially in the years ahead. CLINICAL TRIALS LIABILITY INSURANCE REDEFINING THE BOUNDARIES OF RISK MANAGEMENT, NOW AND INTO THE FUTURE THE SOLUTION: Participation in clinical trials always carries some risk, including but not limited to: injuries resulting from the research procedure, injuries caused by the administration of medication or medical procedures, or an investigator’s failure to follow the protocol or to perform the procedures correctly. Having adequate and properly executed coverage will protect not only the sponsor, but investors, investigators and other parties involved in the management of the trial. Camargue’s Clinical Trials Liability coverage provides unique protection. It offers the maximum liability insurance for sponsors and practitioners involved in the trial, demonstrates prudent financial management, protects the safety of test subjects and ensures the ethical behaviour of those to whom the subjects have entrusted themselves for medical research. Research companies, clinical trial service companies, including clinical trial facilitators, medical device manufacturers, pharmaceutical manufacturers, biotechnology researchers and developers, and contract research organisations should all ensure that the clinical trial with which they are involved has this specialised liability coverage – it could ultimately result in protecting the clinical trial from being halted mid-term due to the financial implications of a liability suit. RISK MANAGEMENT SERVICES INCLUDED IN THE POLICY COVER: VALUE-ADDED SERVICES Camargue’s unique M3 approach to insurance is geared towards managing, mitigating and migrating critical business risks – an outcome achieved through the provision of value-added risk benefits to policyholders. Notwithstanding the coverage provided in terms of the policy, the additional risk management benefits further enhance the Camargue product offering and go way beyond simple insurance. The overall result is a well-rounded and complete solution to the risks faced by businesses. - Private Arbitration Service: Offered through TOKISO Dispute Settlement - this service works towards fast, equitable resolution of disputes between the insured and their clients. As far as possible court proceedings are avoided saving time, money and more importantly reputation